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Abstract: In this study, a two-step multiplex reverse transcription-polymerase chain reaction (mRT-PCR) was developed and evaluated
using designed primers for the simultaneous detection and differentiation of Turkish foot-and-mouth disease virus (FMDV) serotypes
A and O from clinical samples. In the method, a mix of one universal reverse primer designed from the 2B gene and two serotypespecific forward primers designed from the hypervariable regions of the capsid VP1-1D coding gene of FMDV were used. Totally, 272
FMDV-infected samples collected between 2006 and 2008 constituted the material of the study. mRT-PCR was compared to ELISA in
terms of positivity percentage (%) and the difference between the two tests was found to be statistically significant (P < 0.05). In the
study, 148 (54.4%) of 272 samples were undetermined by ELISA. Ninety-nine (66.8%) of these 148 undetermined samples were found
FMDV RNA-positive with mRT-PCR. Consequently, the diagnostic sensitivity and specificity of mRT-PCR was determined as 95% and
84%, respectively. The study showed that mRT-PCR was more efficient than ELISA and concluded that the technique can be used as an
alternative to ELISA for molecular typing of FMDV samples. This is the first report providing the differentiation of FMDV serotypes A
and O in Turkey by mRT-PCR.
Key words: Foot-and-mouth disease virus, diagnosis, mRT-PCR

1. Introduction
Foot-and-mouth disease (FMD) is a global, highly
contagious, and economically devastating disease of both
wild and domestic cloven-hooved animals. The FMD
virus (FMDV) belongs to the genus Aphthovirus of the
family Picornaviridae. It is 28–30 nm in size and contains a
positive-stranded RNA genome of about 8500 nucleotides.
FMDV has 7 serotypes (A, O, Asia-1, SAT 1, SAT 2, SAT 3,
C) and many subtypes. Although cross-immunity has not
been observed among the serotypes, partial immunity has
been reported among the subtypes (1–3). High mutation
rates and quasispecies population structure in FMDV
triggers many antigenically and genetically divergent
strains within each serotype of the virus, all of which cause
difficulties in control of the disease (4–6).
In Turkey, FMD is generally endemic with different
subtypes of O, A, and Asia-1 serotypes since 1952. FMDV
A serotype-A Iran 2005 (ASIA topotype) and O serotype-O
Panasia II (ME-SA topotype) strains were prevalent
during the study period (2006–2008). FMDV strain A Iran
2005 caused many outbreaks starting at the end of 2005
and occurred through 2006. An FMDV serotype Asia-1
* Correspondence: beyhan.sar@gmail.com
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outbreak occurred in 2011, 9 years after the first Asia-1
epidemic in 2002. There was no Asia-1 outbreak during
this study period.
FMDV diagnosis is based on clinical signs, followed
by confirmation by laboratory tests. Virus isolation in
cell culture is considered to be the gold standard for
FMDV detection. However, it takes 1–4 days to obtain a
definitive result, thus delaying the initiation of outbreak
control procedures in the field. Antigen-detection ELISA
is considered by the World Organisation for Animal
Health (OIE) as the preferred method for FMDV antigen
detection and serotyping (7,8). Although ELISA is
much faster than virus isolation, it has lower sensitivity
(9,10). In general, samples are first tested by ELISA, and
consequently ELISA-negative samples were inoculated
into cell culture followed by the confirmation of the virus
serotype by ELISA in the case of virus propagation (8).
This process is time-consuming. Therefore, it is essential to
have a reliable molecular technique for the rapid typing of
FMDV. In particular, RT-PCR studies for typing of FMDV
(9,11–15) and its derivatives such as Ag-RT-PCR ELISA
(16), mRT-PCR (12,13,17–20), and real-time RT-PCR
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(21,22) have provided new approaches for rapid detection
and typing of FMDV. For example, mRT-PCR can detect
different genes simultaneously in the same PCR reaction
mix, providing a useful technique for FMDV typing.
Nevertheless, there are very limited articles on FMDV
typing with mRT-PCR (12,13,17,18,20). Multiplex primer
design for FMDV typing is quite a challenging step. The
major obstacle is the high variability in the FMDV genome
due to high mutation rates and lack of sequences that are
conserved within but restricted to a particular serotype
(21). Another problem originates from the nature of the
mRT-PCR technique, as a number of primers have to be
used in same PCR reaction and these may interact with
each other and finally may limit the sensitivity of the test
(23,24). The aim of the current study was to develop a twostep mRT-PCR for the differentiation of FMDV A and O
serotypes circulating in Turkey.
2. Materials and methods
2.1. Cells and virus samples
Vaccine strains O1/Manisa/TUR/69, O/JOR5/2006, A22/
Mahmatlı/TUR/64, and A/TUR1/2006 maintained in
a BHK-21 (baby hamster kidney) cell line were used as
the reference strains for serotypes O and A during the
test optimization. For evaluation of mRT-PCR, samples
including tongue and heart epithelia were collected from
272 cattle suspected of being infected with FMD from
different provinces of Turkey. The numbers of samples
collected per year were as follows: 50 of 272 samples were
collected in 2006, 119 in 2007, and 103 in 2008.
First, all 272 samples were subjected to indirect ELISA.
Sixty-five of 272 ELISA-tested samples were inoculated
into cell culture to evaluate mRT-PCR efficiency with
cultured samples. The number of samples used in the
study according to sample type is summarized in Table 1.
2.2. Virus isolation
Epithelium samples (1 g) were taken from phosphatebuffered saline (PBS)/glycerol and a suspension was
prepared by grinding the sample with sterile sand in a sterile
Table 1. Sample numbers according to sample type.
Sample numbers
Sample type
Clinical*

Cell-cultured

207

65

272
*Tongue and heart epithelia samples were collected as clinical
specimens.

pestle and mortar with 9 mL of PBS. This homogenate was
clarified on a bench centrifuge at 3000 rpm for 30 min.
The supernatant was filtered with 0.45-µm and 0.20-µm
filters and such suspensions of field samples suspected to
contain FMDV were inoculated onto established BHK-21
cell lines (1 mL/25-cm2 cell culture flask). Cell cultures
stayed in an incubator for adsorption at 37 °C for 1 h and 5
mL of G-MEM (Glasgow MEM BHK 21 1X (GIBCO, Cat.
No. 21710) virus medium was added and cultures were
examined for cytopathic effect (CPE) for 48 h. If 75%–80%
CPE was detected, the cells were frozen and thawed, then
centrifuged at 4 °C and 3000 rpm for 30 min. Finally, the
supernatant was taken, labeled, and stored at –70 °C until
use.
2.3. Oligonucleotide primers
The universal reverse primer (BES-VP1R) was designed
from the conserved 2B region based on the alignment of
VP1 genomic sequences of serotype O and A selected from
the GenBank nucleotide database. Two serotype-specific
forward primers (O1F and A1F) were designed from the
hypervariable regions of the capsid coding gene (VP1/1D)
following the alignments of VP1 (1D) gene sequences of
serotypes O and A selected from the GenBank nucleotide
database and conserved sequences unique to each serotype
were identified and used for primer design. Details of the
designed oligonucleotide primers are shown in Table 2.
All steps of primer design were performed with a
commercial licensed software package (MacVector, USA)
and free web-based computer programs (Primer 3.0,
mfold). Each set of primers was confirmed for specificity
by BLAST searches.
2.4. RNA extraction and reverse transcription (RT)
RNA was isolated with TRIzol (GIBCO Life Technologies,
UK) according to the manufacturer’s protocol. The
method of choice was the one developed by Chomczynski
and Sacchi using guanidine thiocyanate (25). Briefly, virus
suspensions were taken from deepfreeze, then thawed at
room temperature, and 200 µL of chloroform was added
to the suspensions. The aqueous layer containing the RNA
was removed, and the RNA was recovered by precipitation
with isopropyl alcohol and washed with 70% ethanol. The
RNA was resuspended in RNase-free water. RNA purity
was also measured spectrophotometrically (260/280).
RNA concentrations and purities were 55–172 ng/µL and
1.50–1.90 in the samples, respectively.
RT reaction was modified and performed according
to the recommendations of Sambrook et al. (26). First,
5 µL of template RNA and 2 µL of 10 µM primer (novel
designed primer BES) were heated to 65 °C for 5 min and
cooled to 4 °C. The total RT reaction volume of 20 µL was
obtained by adding 4 µL of 5X AMV RT buffer, 0.5 µL of
10 mM dNTPs, 0.5 µL of 20 U RNasin, 0.5 µL of DTT, 0.5
µL of 10 U AMV reverse transcriptase, and 7 µL of RNase-
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Table 2. Primers designed for FMDV typing in the study.
Primer

Sequence

Sense

Gene

Serotype

Tm

PCR product (bp)

A1F

ACTCTACTGCCCYAGRCCACTG

+

VP1

A

60 °C

218

O1F

CGGGTGACTGAACTGCTTTA

+

VP1

O

61 °C

253

BES

TTGACATGTCCTCCTGCATCT

-

2AB

Genus-specific

60 °C

IUB nucleotide symbols (Y: C or T; R: A or G).

free water. RT was carried out at 50 °C for 60 min. The
reaction was terminated by incubation at 85 °C for 5 min
and obtained cDNA was stored at –20 °C until use.
2.5. Polymerase chain reactions (uniplex and multiplex)
and mRT-PCR optimization
Uniplex and multiplex RT-PCR reactions were modified
and performed according to the recommendations of
Sambrook et al. (26) and Henagariu (24). mRT-PCR was
carried out using a HotStar Taq DNA Polymerase Kit
(QIAGEN, Germany). Uniplex RT-PCR was carried out to
determine whether the designed primers amplified their
respective target sequences. The uniplex RT-PCR reaction
mix and cycling conditions were the same as those for
mRT-PCR, except that 1.5 µL of of 25 mM MgCl2 was used.
The PCR reaction mix contained 2 µL of cDNA, 2.5 µL of
10X PCR buffer, 3.0 µL of 25 mM MgCl2, 0.5 µL of 10 mM
dNTP mix, 2 µL of 20 µM genome-specific reverse primer,
1 µL of 10 µM of each serotype-specific forward primer,
0.25 µl of 1.25 U HotStar Taq DNA polymerase, and 12.75
µL of RNase-free water. All RT-PCRs were performed in
a final reaction volume of 25 µL for one cycle at 94 °C for
15 min; 30 cycles each of 94 °C for 1 min, 59 °C for 1 min,
and 72 °C for 2 min; and one finally cycle of 72 °C for 5
min. The PCR products were analyzed on 1.5% agarose
gel and visualized by ethidium bromide staining. Based on
the primer performances in uniplex RT-PCR, a universal
reverse primer and a serotype-speciﬁc forward primer
specific to each serotype were chosen. The speciﬁcity of
these primers when combined to amplify homologous
cDNA templates was examined using the HotStar Taq
Polymerase Kit (QIAGEN). The rest of the reaction mix
and cycle conditions were the same as in the uniplex RTPCR. Optimization of mRT-PCR was performed with
varying reaction components and cycle conditions for
each parameter at a time.
2.6. Analytical sensitivity and specificity of mRT-PCR
To determine analytical sensitivity (detection limit),
7.5 TCID50/mL O and A serotype viruses were prepared
and viruses using a series of 10-fold dilution were tested
by ELISA and mRT-PCR simultaneously. For testing the
specificity of the method, bovine herpes virus-1 (BHV-
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1: strain Germany, strain 2204, and strain Schönböken),
bovine viral diarrhea virus (BVD: genotype 1, NADL, and
genotype 2 CS8644), vesicular stomatitis virus (strains
Indiana and New Jersey), and blue tongue virus (BTV:
serotypes 1 to 24) were used.
2.7. Statistical methods
The degree of agreement between ELISA and uniplex and
mRT-PCR assays in detecting and serotyping FMDV was
calculated by Cohen’s kappa values (kappa statistics). The
mean positivity of ELISA and mRT-PCR were compared
by Student’s t-test. For the description of the agreement of
the results and determination of the diagnostic sensitivity
of mRT-PCR, Spearman correlation coefficients were
calculated (SPSS 11.0, SPSS Inc., USA).
2.8. Sensitivity of mRT-PCR
As the first step, the degree of agreement between ELISA,
uniplex assays, and mRT-PCR assays in detecting and
typing FMDV was calculated. For this purpose, 45 out of
272 samples were tested with uniplex RT-PCR. Since the
degree of accuracy between PCR and ELISA was rather
low (kappa = 0.2), mRT-PCR was compared to ELISA
in terms of the % positivity. Degree of accuracy between
uniplex RT-PCR and mRT-PCR was high (kappa = 0.73).
Therefore, uniplex RT-PCR was used for determination of
mRT-PCR diagnostic sensitivity.
3. Results
3.1. mRT-PCR
The primers were cocktailed together in one multiplex
reaction regarding their suitability to simultaneously
amplify their respective targets determined previously in
uniplex RT-PCRs. Amplicons of the desired sizes of 253
bp and 218 bp in length were obtained respectively for
serotypes O and A (Figure).
3.2. mRT-PCR optimization
mRT-PCR was performed with previously characterized
A and O serotypes at annealing temperatures of 55–61
°C. Other reaction conditions were kept constant. At
temperatures of 59 °C and 61 °C specific amplification
of the target sequence was obtained with both of the two
serotypes without important variation in band intensity.
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fourth dilution step (104.5 TCID50/mL) for the FMDV
A serotype. ELISA was found positive just until the
second dilution step for both serotypes of FMDV (105.5
TCID50/mL). Hence, mRT-PCR revealed a better analytic
sensitivity than ELISA.
mRT-PCR clearly detected and differentiated almost all
FMDV samples, yielding the expected 218-bp and 253-bp
PCR products for serotypes A and O, respectively. Only 12
samples gave negative results with mRT-PCR. Nonspeciﬁc
reactions or cross-amplifications were not observed in
the assay. The difference between ELISA and mRT-PCR
results was found to be statistically significant with both
clinical and cell-cultured samples (P < 0.05). In the study,
148 (54.4%) of 272 samples were undetermined by ELISA,
and 99 (66.8%) of these were found positive with mRTPCR. The detailed results of mRT-PCR and ELISA assays
are shown in Tables 3 and 4.

Figure. mRT-PCR results with FMDV primers.
M: 100-bp DNA ladder (Fermentas, Vilnius, Lithuania). Lane N:
Negative control, lane 1: mRT-PCR result of primer pairs (A1F,
O1F, BES) and FMDV serotypes A and O cDNA.

4. Discussion
Rapid identification of serotypes is a crucial step to
understand the epidemiology of FMDV in a geographic
location. Furthermore, it is of utmost importance to
decide the appropriate vaccine strains for the control of a
novel virus outbreak. The gold standard “virus isolation”
and antigen detection sandwich ELISA methods have
been used for FMDV typing for many years. However,
low sensitivities and longer analysis time make these
two methods inadequate. RT-PCR-based FMDV typing
methods (RT-PCR, mRT-PCR, real-time PCR) provide
the required advantages to researchers since they are
faster and more sensitive than ELISA and virus isolation
(13,18,21). In one of these techniques, mRT-PCR, more

The best amplifications were obtained with final PCR
concentrations of 1.5 mM MgCl2 and 200 µM dNTPs. Taq
DNA polymerase (1.25 U) was used in mRT-PCR for both
of the serotypes. Primers were used in 10 µM concentrations
for serotype-specific primers and 20 µM for the reverse
primer since the latter was used for both serotype-specific
primers in the reaction. Changing numbers of cycles (30
and 40 cycles) were studied for optimal performance. The
lower cycle number was preferred since no difference was
found in PCR results due to the cycle numbers.
3.3. Comparison of mRT-PCR and ELISA
mRT-PCR was found positive in the fifth dilution step
(103.5 TCID50/mL) for the FMDV O serotype and in the
Table 3. Typing results of samples with mRT-PCR and ELISA assays.
ELISA-positive samples
Serotype

ELISA-negative samples

mRT-PCR positive

mRT-PCR negative

mRT-PCR positive

mRT-PCR negative

Field

Cell-cultured

Field

Cell-cultured

Field

Cell-cultured

Field

Cell-cultured

O

32

14

5

3

38

9

28

2

A

37

29

3

1

46

6

18

1

Total

69

43

8

4

84

15

46

3

Table 4. Comparison (% positivity and statistical importance) of mRT-PCR and ELISA results.
Sample

mRT-PCR (positive/total)

ELISA (positive/total)

Statistical importance (P)

Total

77.5% (211/272)

45.5 % (124/272)

P < 0.05

Clinical

73.9% (153/207)

37.1% (77/207)

P < 0.05

Cell-cultured

89.2% (58/65)

72.3% (47/65)

P < 0.05
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than one target sequence could be amplified in the same
PCR reaction since it helps to investigate different genes in
the same PCR reaction simultaneously (23,24). Therefore,
in this study, mRT-PCR was used to differentiate FMDV
serotypes.
Reliable and efficient mRT-PCR amplification depends
mostly on the quality of the designed primers (24,27). A
poorly designed primer pair may amplify a PCR product
in low quantity or no product at all and thus be insensitive.
This may be due to nonspecific amplification, primer-dimer
formation, or amplicon secondary structure, leading to the
failure of the reaction (27,28). Hence, all of the multiplex
primers should be designed according to the above
mentioned parameters, which is crucial for successful mRTPCR (24,27). VP1-1D is a most immunodominant region
defining viral antigenicity and is responsible for serotype
and subtype differences (2,29). Similar to previous studies
(12,13,17), in this research, the VP1-1D gene region was
preferred for serotype-specific primer design. It is known
that there are 30%–50% nucleotide differences between the
FMDV VP1 genes (3). This seems to facilitate serotypespecific primer design. However, it is a challenging task,
depending on the high variability of the FMDV genome,
and lack of enough sequences that are conserved within
but restricted to a particular serotype causes the crossreactions in mRT-PCR assays (21). We thus selected
optimal primer pairs providing minimum cross-reactions.
Nevertheless, during FMDV replication, due to its errorprone nature and quasispecies structure, designed primers
will not always succeed in detecting some virus strains
(14). For this reason, regarding probable FMDV serotype
variability in a particular geographic location, revisions of
the primer sequences should be performed periodically.
For a diagnosis laboratory, tailoring primers for FMDV
should be a continuous dynamic action evolving in parallel
to FMDV population dynamics in the field. Expecting
high mutation rates, especially in FMDV A serotypes,
degenerate primers might be a rational design approach
to overcome this disadvantage. For this reason, degenerate
primers were designed and used for identification of
FMDV serotype A in this study. In some of the previous
studies, degenerate primers were also used (12,18,20).
However, Reid et al. (14) mentioned that degenerate
primers could cause a decrease in serotype specificity.
In some studies on mRT-PCR for FMDV typing
(12,13,17), it was indicated that RT-PCR did not
successfully work with clinical specimens. Conversely,
another study (18) showed that mRT-PCR got satisfactory
results with clinical samples; the researchers reported
that the method has better efficiency than ELISA and
mRT-PCR might be used as a second-round test to define
ELISA-negative samples. In other research (20), one-step
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mRT-PCR was studied for FMDV typing and the results
were quite satisfactory with clinical samples.
In the current study, a statistically significant difference
(P < 0.05) was obtained regarding % positivity results
between ELISA and mRT-PCR in clinical specimens. This
result is similar to the results reported by Grindharan
et al. (18) since ELISA and PCR detect different viral
components: capsid 146S antigen and viral RNA,
respectively. FMDV has no viral envelope. For this
reason, it can be easily degenerated in field conditions
by high temperature, acidic pH, etc., and RNA can also
be degraded. Nevertheless, such samples may still have
adequate quantities of intact RNA for RT-PCR (30).
The most essential disadvantage of PCR diagnosis
is false negative results due to PCR inhibitors inherent
to the sample or manipulation errors in the laboratory.
Therefore, clinical sample quality has the same degree
of importance as primer optimization conditions in the
laboratory. Although PCR specificity is affected mainly by
primer design, PCR sensitivity is affected by many factors
such as RNA extraction methods, RNA quality in the
field samples, or primer design (24,26,27). Hence, welldesigned and optimized PCR conditions, minimization
of manipulation errors in the laboratory, and follow-up of
current circulating strains as soon as possible will provide
important implications for FMDV molecular diagnosis
and FMD control.
In conclusion, this was the first study to be conducted
to evaluate mRT-PCR efficiency for FMDV diagnosis in
Turkey and the study showed that the present method
is more sensitive and specific than ELISA. Diagnosis
techniques based on PCR are crucial for rapid identification
of an epidemic serotype and thus the vaccine strain.
Development of real-time mRT-PCR is urgently needed
to improve the diagnostic sensitivity and the specificity of
conventional gel-based mRT-PCR and a loop-mediated
isothermal amplification method for rapid identification
of FMDV serotypes in the field.
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